Evidence map›Paper›PMID 42163640›Full record

ArticleBritish journal of haematology2026

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

Frank Neumann, Claudia Schormann, Onur Cetin, Igor A Kos, Moritz Bewarder, Eva C Schwarz, Stefan Lohse, Stephanie Maurer, Philipp B Staber, Joerg T Bittenbring and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Frank NeumannJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Claudia SchormannJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Onur CetinJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.ORCID https://orcid.org/0009-0007-3441-7743
Igor A KosJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.ORCID https://orcid.org/0000-0002-2518-7559
Moritz BewarderDepartment of Oncology, Bethanien Hospital, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0003-0926-6895
Eva C SchwarzBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.ORCID https://orcid.org/0000-0002-6503-4864
Stefan LohseInstitute of Virology, Saarland University, Homburg, Germany.
Stephanie MaurerJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Philipp B StaberJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Joerg T BittenbringJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Sigrun SmolaInstitute of Virology, Saarland University, Homburg, Germany.
Konstantinos ChristofyllakisJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Markus HothBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Lorenz ThurnerJosé Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.ORCID https://orcid.org/0000-0002-8167-2989

Funding

Dr. Rolf M. Schwiete Stiftung
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADCCBCMACD19CD20CD38CD79bprimary CD20‐negative aggressive B‐NHLSLAMF7

Identifiers

PMID42163640
PMCPMC13340470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.